Takeda Pharmaceutical Co Ltd (TKPHF) Notes Payables (2017 - 2018)
Takeda Pharmaceutical (TKPHF) posted quarterly Notes Payables of $3.3 billion for Q4 2018, up 19.65% year-over-year from $2.8 billion in Q4 2017, and up 19.65% quarter-over-quarter from $2.8 billion in Q4 2017.
Takeda Pharmaceutical Co Ltd (TKPHF) Notes Payables (2017 - 2018) Analysis & Trends
Takeda Pharmaceutical's Notes Payables history runs 2 years deep, the most recent figure standing at $3.3 billion for Q4 2018.
- In Q4 2018, Notes Payables rose 19.65% year-over-year to $3.3 billion; the TTM figure through Dec 2018 stood at $3.3 billion (up 19.65% YoY), while the FY2018 annual figure was $3.3 billion, up 19.65% from the prior year.
- Notes Payables for Q4 2018 stood at $3.3 billion, up from $2.8 billion in the prior quarter.
- The five-year high for Notes Payables was $3.3 billion in Q4 2018, with the low at $2.8 billion in Q4 2017.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 3.34 Bn |
| Dec 31, 2017 | 2.79 Bn |